This years’s PM Society Awards, held on the 24th of January at Grosvenor House, saw Havas Lynx Group take home an impressive seven Gold awards across work for six di...

Enhertu (trastuzumab deruxtecan) has yielded high-level results from the positive registrational Phase II trial - DESTINY-Gastric01 - AstraZeneca and Daiichi Sankyo ...

A new study has revealed that Oncimmune’s EarlyCDT Lung test is more effective than the traditional computed tomography (CT) surveillance in lung cancer diagnosis. ...

Today, the U.S. Food and Drug Administration (FDA) approved Tepezza (teprotumumab-trbw) for the treatment of adults with thyroid eye disease, a rare condition where...

The Amgen Foundation and the Faculty of Arts and Sciences at Harvard University (Harvard FAS) today announced the global launch of LabXchange™, a free online scienc...

The National Institute for Health and Care Excellence (NICE) has released a draft guidance not recommending Janssen’s Stelara (ustekinumab) for moderately to severel...

UK-based PhoreMost has announced that it has entered into a multi-project collaboration with Otsuka Pharmaceutical, a company dedicated to the research and developme...

Jazz Pharmaceuticals has received a European Marketing Authorisation for Sunosi (solriamfetol) as a treatment for excessive daytime sleepiness in adults with na...

Platform gives researchers access to previously undiscovered data to guide evaluation and validation of new drug targets, pathogen identification, disease diagnosis,...

End-to-end robotic platform provides biotechnology companies, pharmaceutical corporations and academic centres with cost-effective and reproducible drug discovery da...